G 367 (Topiramate Extended-Release 25 mg)
Pill with imprint G 367 is Beige / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Glenmark Pharmaceuticals Inc..
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 367
Topiramate Extended-Release
- Imprint
- G 367
- Strength
- 25 mg
- Color
- Beige / Gray
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Pharmaceuticals Inc.
- National Drug Code (NDC)
- 68462-0372
Related Images for "G 367"
More about topiramate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 1125 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
Consumer resources
- Other brands
- Topamax, Trokendi XR, Qudexy XR, Topamax Sprinkle, Topiragen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.